Charles Schwab’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $778K | Buy |
|
|||||
|
2025
Q2 | $475K | Sell |
|
|||||
|
2025
Q1 | $760K | Sell |
|
|||||
|
2024
Q4 | $1.75M | Buy |
|
|||||
|
2024
Q3 | $2.75M | Sell |
|
|||||
|
2024
Q2 | $2.26M | Buy |
|
|||||
|
2024
Q1 | $2.18M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $462K | Buy |
|
|||||
|
2023
Q2 | $635K | Sell |
|
|||||
|
2023
Q1 | $995K | Sell |
|
|||||
|
2022
Q4 | $2.1M | Buy |
|
|||||
|
2022
Q3 | $3.09M | Buy |
|
|||||
|
2022
Q2 | $2.06M | Buy |
|
|||||
|
2022
Q1 | $6.63M | Buy |
|
|||||
|
2021
Q4 | $8.52M | Buy |
|
|||||
|
2021
Q3 | $11.6M | Buy |
|
|||||
|
2021
Q2 | $5.32M | Buy |
|
|||||
|
2021
Q1 | $2.58M | Buy |
|
|||||
|
2020
Q4 | $2.21M | Buy |
|